Active I/O Clinical Trials

by accessing the database you agree to the following:

[UPDATED 31MAY2024] — THIS DATABASE IS SUBJECT TO CHANGE WITHOUT PRIOR NOTICE. Disclaimer and Disclosure Statement for Cure Glioblastoma, Inc.'s Immunotherapy Clinical Trial Database for Brain Cancer (ICTB). The information provided in the ICTB is intended for informational purposes only and should not be considered as medical advice, diagnosis, or treatment recommendations. This database is created by Cure Glioblastoma, Inc. based on our own criteria and methodology, which includes US interventional trials with at least one immuno-oncology (I/O) modality. While we strive to provide accurate and up-to-date information, the field of brain cancer research is continually evolving, and new findings may emerge after the publication of this database. Therefore, we cannot guarantee the accuracy, completeness, or timeliness of the information provided.Patients should not make decisions about their treatment solely based on this database. It is crucial to consult with qualified healthcare professionals to discuss individual medical needs, treatment options, and eligibility for clinical trials. Inclusion or exclusion of a clinical trial on this database does not constitute an endorsement or disapproval by Cure Glioblastoma, Inc. It is important to note that patients may be excluded from participating in a clinical trial listed here based on individual eligibility criteria, which may include factors such as age, medical history, current health status, and previous treatments. Exclusion from a trial does not necessarily reflect the potential efficacy or safety of the treatment being studied. Furthermore, participating in any clinical trial involves inherent risks and potential side effects, which will be clearly outlined during the informed consent process. While we strive to list trials that show promise and have a favorable risk-benefit profile, Cure Glioblastoma, Inc. is not responsible for any adverse events, damages, or harm that may result from participating in a listed clinical trial.By accessing and using the ICTB, you acknowledge and agree that Cure Glioblastoma, Inc. is not responsible for any actions taken based on the information provided and that you assume full responsibility for your use of the database and any outcomes resulting from such use. If you have any questions or concerns about the information provided in this database, please consult with your healthcare provider.